Table 1.
Demographic overview of the investigated NSCLC patient cohort. IQR – interquartile range. N.D. – not determined.
| Gender | |
|---|---|
| female | 45.5% (10/22) |
| male | 54.5% (12/22) |
| Age | |
| [years] (IQR) | 64 (55.75 – 73.25) |
| Tumor | |
| Adenocarcinoma | 63.6% (14/22) |
| Squamous cell carcinoma | 18.2% (4/22) |
| Large cell carcinoma | 9.1% (2/22) |
| Mixed | 4.5% (1/22) |
| N.D. | 4.5% (1/22) |
| Metastasis | |
| Lymph node | 63.6% (14/22) |
| Bone | 18.2% (4/22) |
| Overall survival | |
| [days] (IQR) | 345 (194.25–1049.75) |